Richard Anthony Cunningham - 04 Apr 2025 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: ANEB
Reported as of: 04 Apr 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Apr 2025, 21:41:34 UTC
Prior SEC filing: 10 Dec 2024
Source filing: View source filing
Reporting owner signature: /s/ Daniel George, as attorney-in-fact

Key filing fact

Richard Anthony Cunningham filed Form 4 for Anebulo Pharmaceuticals, Inc. (ANEB) on 07 Apr 2025.

Key facts

This page summarizes Richard Anthony Cunningham's Form 4 filing for Anebulo Pharmaceuticals, Inc. (ANEB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 07 Apr 2025, 21:41.

Change

Previous filing in this sequence was filed on 10 Dec 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ANEB transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +316,352
Change %
Price: $0.000000
Shares after: 316,352
Date: 04 Apr 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 316,352
Exercise price: $1.02
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

One-sixteenth (1/16) of the shares subject to the option vested and became exercisable on April 4, 2025, with the remainder scheduled to vest and become exercisable in fifteen (15) equal quarterly installments on each July 15, October 15, January 15, and April 15 thereafter, vesting fully on January 15, 2029, in each case, subject to the Reporting Person's continued service to the Issuer through each vesting date.